Chronic lung conditions such as chronic obstructive pulmonary disease (COPD) and pulmonary hypertension can lead to a serious condition known as pulmonary heart diseases. When the blood vessels in the lungs become damaged or narrowed, the right side of the heart faces increased pressure, leading to strain and enlargement of the heart’s right ventricle. Over time, this can result in right heart failure. Pulmonary heart diseases often go unnoticed in the early stages, but with appropriate treatment, such as oxygen therapy, medications to reduce lung pressures, and lifestyle modifications, patients can manage their condition effectively. Addressing the root cause—often the underlying lung disease—remains crucial in improving outcomes.
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile